- Home
- NNNN vs BTBT Comparison
NNNN vs BTBT Comparison
Compare NNNN & BTBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NNNN
- BTBT
- Stock Information
- Founded
- NNNN 2021
- BTBT 2015
- Country
- NNNN Germany
- BTBT United States
- Employees
- NNNN N/A
- BTBT N/A
- Industry
- NNNN Biotechnology: In Vitro & In Vivo Diagnostic Substances
- BTBT Finance: Consumer Services
- Sector
- NNNN Health Care
- BTBT Finance
- Exchange
- NNNN Nasdaq
- BTBT Nasdaq
- Market Cap
- NNNN 369.6M
- BTBT 437.8M
- IPO Year
- NNNN 2025
- BTBT 2018
- Fundamental
- Price
- NNNN $16.10
- BTBT $2.33
- Analyst Decision
- NNNN
- BTBT Strong Buy
- Analyst Count
- NNNN 0
- BTBT 3
- Target Price
- NNNN N/A
- BTBT $6.33
- AVG Volume (30 Days)
- NNNN 78.0K
- BTBT 15.0M
- Earning Date
- NNNN 01-01-0001
- BTBT 08-18-2025
- Dividend Yield
- NNNN N/A
- BTBT N/A
- EPS Growth
- NNNN N/A
- BTBT N/A
- EPS
- NNNN 0.06
- BTBT N/A
- Revenue
- NNNN $8,185,146.00
- BTBT $102,037,923.00
- Revenue This Year
- NNNN N/A
- BTBT $31.34
- Revenue Next Year
- NNNN N/A
- BTBT $40.97
- P/E Ratio
- NNNN $286.95
- BTBT N/A
- Revenue Growth
- NNNN 21.95
- BTBT 52.44
- 52 Week Low
- NNNN $5.18
- BTBT $1.69
- 52 Week High
- NNNN $18.50
- BTBT $5.74
- Technical
- Relative Strength Index (RSI)
- NNNN N/A
- BTBT 45.66
- Support Level
- NNNN N/A
- BTBT $2.47
- Resistance Level
- NNNN N/A
- BTBT $2.66
- Average True Range (ATR)
- NNNN 0.00
- BTBT 0.17
- MACD
- NNNN 0.00
- BTBT -0.04
- Stochastic Oscillator
- NNNN 0.00
- BTBT 2.38
About NNNN Anbio Biotechnology Class A Ordinary Shares
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.
About BTBT Bit Digital Inc.
Bit Digital Inc is engaged in the Bitcoin mining business, Ethereum staking activities and specialized cloud-infrastructure services for artificial intelligence applications through its wholly owned subsidiaries. Its mining platform operates with the primary intent of accumulating bitcoin which may sell for fiat currency from time to time depending on market conditions. The Company has four reportable segments: digital asset mining, cloud services, colocation services, and ETH Staking. It generates majority of its revenue from digital asset mining.